# Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions

> **NCT00418067** · PHASE4 · COMPLETED · sponsor: **Seung-Jung Park** · enrollment: 2645 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Endeavor
- **DEVICE:** Cypher
- **DEVICE:** Taxus Liberte

## Key facts

- **NCT ID:** NCT00418067
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 2645 (ACTUAL)
- **Last updated:** 2012-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418067, "Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00418067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*